Trial Profile
Clinical Trials Insight: 700009617
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 16 Jun 2010
Price :
$35
*
At a glance
- Drugs TRU 015 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Trubion Pharmaceuticals
- 27 Nov 2006 Interim results were presented at ACR/ARHP 2006.
- 01 Dec 2005 New trial record.